Economics of Innovation

Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.

95 - 1978 health care research expendituer
Publication

Health Care Research Expenditure

1 June 1978

In the financial year 1976-77 over £220 million was spent on health care research in the United Kingdom. Taking account of recent expenditure growth and making…

Cracks through the ice on a melting glacier in Alaska
Publication

Pharmaceutical Prices: A continental view

1 April 1978

It has not normally been OHE policy to reprint articles which have previously been published elsewhere. However, it seemed desirable to make an exception for this…

Brand names in prescribing cover page
Publication

Brand Names in Prescribing

1 September 1976

To present a balanced view of the brand name/generic controversy and the associated field of bioavailability. Many have discussed these problems; scientists, politicians, industrialists, legislators, hospital…

The canberra hypothesis cover page
Publication

Canberra Hypothesis: the Economics of the Prescription Medicine Market

1 July 1975

The Office of Health Economics delivered a paper to the Pharmaceutical Sciences Section of the Australian and New Zealand Association for the Advancement of Science at the Academy of Sciences in Canberra.

Hospital purchasing cover page
Publication

Hospital Purchasing

1 September 1972

Out of £868 minion spent on the revenue account of the hospital service in England and Wales in 1970, £242 million, or a little over one…

The pharma society cover page
Publication

Pharmaceutical Industry and Society: a Study of the Changing Environment and Economics of the International Industry

1 July 1972

This paper is based on a symposium held at the Imperial College of Science and Technology by the Office of Health Economics in 1972. Our ancestors…

142 - 1984 pharmaceuticals among the sunrise
Publication

Pharmaceuticals Among the Sunrise Industries

1 February 1984

The performance of the United Kingdom economy has been the subject of much critical comment in recent years. Of course, economic achievement can be viewed from…

Economics and innovation in the pharma industry cover page
Publication

Economics and Innovation the Pharmaceutical Industry

1 July 1969

This book contains the third series of Winter Lectures organised by the Office of Health Economics, and the first to be given after the publication of…

Innovation in industry cover page
Publication

Innovation in Industry: a Factor for Growth

1 July 1969

Over  the  past  few  years  there  has  been  a  growing  concern  with Britain’s record of industrial innovation based upon technology.  This stems from two factors.  Firstly,…